Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Sosei collaborates with DyNAbind to accelerate GPCR drug discovery

Nov. 7, 2018

Secarna and MetP to codevelop transnasal antisense oligonucleotide-based CNS therapeutics

Nov. 7, 2018

Enesi and Sementis collaborate on solid dose vaccine development

Nov. 7, 2018

Eli Lilly and NextCure enter immuno-oncology discovery and development collaboration

Nov. 6, 2018

Denali and Sanofi collaborate to develop RIPK1 inhibitors

Nov. 6, 2018

Distributed Bio collaborates with H3 Biomedicine to discover novel cancer therapeutics

Oct. 31, 2018

NEC and Transgene sign MOU for cancer immunotherapy collaboration

Oct. 30, 2018

Pfizer and Novartis collaborate to study NASH therapy combinations

Oct. 29, 2018

Alexion and Dicerna collaborate on RNAi therapies for complement-mediated diseases

Oct. 25, 2018

Achaogen to share data from LpxC inhibitor antibiotic research program on SPARK platform

Oct. 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...